CAR-T therapy achieves remission in a patient with three autoimmune diseases
For the first time, CAR-T cell therapy has been used to treat a patient with three different autoimmune diseases – autoimmune haemolytic anaemia, immune thrombocytopenia and antiphospholipid syndrome – which were life-threatening and had resisted years of treatment. The patient, who previously required daily blood transfusions, has been in remission for a year without the need for further treatment since then. The case report, published in the journal Med, suggests that these therapies may help treat complex and severe autoimmune diseases.
0